Cytochrome P450 expression in the liver of food-producing animals

Current Drug Metabolism

Volumn 7, Issue 4, 2006, Pages 335-348

  Ioannides, Costas ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Cattle; Cytochromes P450; Deer; Drug metabolism; Food producing animals; Goat; Horse; Pig; Sheep

Indexed keywords

ANTIBODY; ANTIGEN; CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 2A; CYTOCHROME P450 2B; CYTOCHROME P450 2C; CYTOCHROME P450 2D; CYTOCHROME P450 3A; DEXAMETHASONE; DRUG RESIDUE; EPITOPE; GESTODENE; ISONIAZID; KETOCONAZOLE; LIVER ENZYME; MONENSIN; PHENOBARBITAL; PHENYTOIN; QUINIDINE; QUININE; RIFAMPICIN; SALINOMYCIN; SULFAPHENAZOLE; TIAMULIN; TOLTERODINE; TROLEANDOMYCIN; UNINDEXED DRUG; VETERINARY DRUG; XENOBIOTIC AGENT;

ANIMAL; ANIMAL DISEASE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN RECOGNITION; DRUG METABOLISM; DRUG POTENTIATION; DRUG TISSUE LEVEL; DYSENTERY; ENZYME METABOLISM; ENZYME SPECIFICITY; EXPERIMENTAL ANIMAL; HUMAN; NONHUMAN; ORTHOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; RAT; REVIEW; SEQUENCE HOMOLOGY;

ANIMALS; ANIMALS, DOMESTIC; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; LIVER; XENOBIOTICS;

EID: 33646554445     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920006776873544     Document Type: Review

References (134)

1. Danielson, P.B. (2002) Curr. Drug Met., 3, 561-597.
2. Nebert, D.W.; Russel, D.W. (2002) Lancet, 360, 1155-1162.
3. Skene, D.J.; Papapagiannidou, E.; Hashemi, E.; Snelling, J.; Lewis, D.F.V.; Fernandez, M.; Ioannides, C. (2001) J. Pineal Res., 31, 333-342.
4. Rendic, S. (2002) Drug Met. Rev., 34, 83-448.
5. Ioannides, C. Ed. (1996) Cytochromes P450; Metabolic and Toxicological Aspects, CRC Press, Boca Raton.
6. Cheeke, P.R. (1998) Natural Toxicants in Feeds, Forages and Poisonous Plants, Interstate Publishers, Danville, IL.
7. Miller, D.J.; O'Connor, J.J.; Roberts, N.L. (1986) Veter. Record, 118, 73-75.
8. Witkamp, R.F.; Nijmejer, S.M.; Csikó, G.; Van Miert, A.S.J.P.A.M. (1994) J. Vet. Pharmacol. Therap., 17, 317-322.
9. Witkamp, R.F.; Nijmejer, S.M.; Monshouwer, M.; Van Miert, A.S.J.P.A.M. (1995) Drug Met. Disp., 23, 542-547.
10. Eltom, S.E.; Babish, J.G.; Schwark, W.S. (1993) J. Vet. Pharmacol. Therap., 16, 152-163.
11. Eltom, S.E.; Schwark, W.S. (1999) Pharmacol. Toxicol., 85, 65-73.
12. Hansen, T.; Borlak, J.; Bader, A. (2000) Xenobiotica, 30, 27-46.
13. Dupuy, J.; Larrieu, G.; Braun, J.P.; Alvinerie, M.; Galtier, P. (2001) Canad. J. Physiol. Pharmacol., 79, 848-853.
14. Tydé, E.; Olsén, L.; Tallkvist, J.; Larsson, P.; Tjälve, H. (2004) Toxicol. Appl. Pharmacol., 201, 112-119.
15. Velík, J.; Szotáková, B.; Baliharová, V.; Lamka, J.; Avlik, M.; Wsó, V.; Nejdrová, E.; Skálová, L. (2005) Res. Vet. Sci., 78, 255-263.
16. Adali, A.; Arinc, A. (1990) Int. J. Biochem., 22, 1433-1444.
17. Williams, D.E.; Dutchuk, M.; Lee, M.Y. (1991) Xenobiotica, 21, 979-989.
18. Grasso, E.; Longo, V.; Coceani, F.; Gervasi, P.G. (2005) Biochim. Biophys. Acta, 1722, 116-123.
19. Longo, V.; Amato, G.; Santucci, A.; Gervasi, P.G. (1997) Biochem. J., 323, 65-70.
20. Marini, S.; Longo, V.; Mazzaccaro, A.; Gervasi, P.G. (1998) Xeno-biotica, 28, 923-935.
21. Ulrich, A.B.; Standop, J.; Schmied, B.M.; Schneider, M.B.; Lawson, T.A.; Pour, P.M. (2002) Toxicol. Pathol., 30, 247-253.
22. Yang, S-P.; Medling, T.; Raner, G.M. (2003) Compar. Biochem. Physiol., Part C, 136, 297-308.
23. Guengerich, F.P. (1997) Chem-Biol. Interact., 106, 161-182.
24. Chang, T.K.H.; Waxman, D.J. (1996) In Cytochromes P450; Metabolic and Toxicological Aspects, (Ioannides, C. Ed.), CRC Press, Boca Raton.
25. Pelkonen, O.; Sotaniemi, E.A.; Ahokas, J.T. (1985) Br. J. Clin. Pharmacol., 19, 59-66.
26. Lacarelle, B.; Rahman, R.; Desousa, G.; Durand, A.; Placidi, M.; Cano, J.P. (1991) Fund. Clin.Pharmacol., 5, 567-582.
27. Salphati, L.; Benet, Z. (1999) Xenobiotica, 29, 171-185.
28. Boobis, A.R.; Sesardic, D.; Murray, B.P.; Edwards, R.J.; Singleton, A.M.; Rich, K.J.; Murray, S.; De la Torre, R.; Segura, J.; Pelkonen, O.; Pasanen, M.; Kobayashi, S.; Zhi-Guang, T.; Davis, D.S. (1990) Xenobiotica, 20, 1139-1161.
29. Eagling, V.A.; Tija, J.F.; Back, D.J. (1998) Br. J. Clin. Pharmacol., 45, 107-114.
30. Miranda, C.L; Henderson, M.C.; Buhler, D.R. (1998) Toxicol. Appl. Pharmacol., 148, 237-244.
31. Wrighton, S.A.; Schuetz, E.G.; Watkins, P.B.; Maurel, P.; Barwick, J.; Bailey, B.S.; Hartle, H.T; Young, B.; Guzelian, P. (1985) Mol. Pharmacol., 28, 312-321.
32. Clayton, D.F.; Darnell, J.E. Jr (1983) Mol. Cell Biol., 3, 1552-1561.
33. Forster, U.; Luippold, G.; Schwarz, L.R. (1986) Drug Met. Disp., 14, 353-360.
34. Waxman, D.J.; Morrissey, J.J.; Naik, S.; Jauregui, H.O. (1990) Biochem. J., 271, 113-119.
35. Wortelboer, H.M.; De Kruif, C.A.; Van Iersel, A.A.J.; Falke, H.E.; Noordhoek, J.; Blaauboer, B. (1991) Biochem. Pharmacol., 42, 381-390.
36. Ioannides, C.; Parke, D.V. (1990) Drug Met. Rev., 22, 1-85.
37. Guengerich, F.P.; Shimada, T.; (1991) Chem. Res. Toxicol., 4, 391-407.
38. Gooderham, N.J.; Murray, S.; Lynch, A.M.; Yadollahi-Farsani, M.; Zhao, K.; Rich, K.; Boobis, A.R.; Davies, D.S. (1997) Mutat. Res., 376, 53-60.
39. Kawajiri, K.; Hayashi S-I. (1996) In Cytochromes P450: Metabolic and Toxicological Aspects, (Ioannides, C.; Ed.), CRC Press Inc, Boca Raton, pp. 77-97.
40. Rendic, S.; Di Carlo, F.J. (1997) Drug Met. Rev., 29, 413-580.
41. Leung, Y.-K.; Lau, K.-M.; Mobley, J.; Jiang, Z.; Ho, S.-M. (2005) Cancer Res., 65, 3726-3734.
42. Namkung, M.J.; Yang, H.L.; Hulla, J.E; Juchau, M.R. (1988) Mol. Pharmacol., 34, 628-637.
43. Sivapathasundaram, S.; Magnisali, P.; Coldham, N.G.; Howells, L.C.; Sauer, M.J.; Ioannides, C. (2001) Biochem. Pharmacol., 62, 635-645.
44. Nebbia, C.; Dacasto, M.; Giaccherino, A.R.; Albo, A.G.; Carletti, M. (2003) Vet. J., 165, 53-64.
45. Ioannides, C. (1999) Xenobiotica, 29, 109-154.
46. Ioannides, C. (2002) Xenobiotica, 32, 451-478.
47. Szotáková, B.; Baliharová, V.; Lamka, J.; Noinová, E.; Wsó, V.; Velík, J.; Machala, M.; Nea, J.; Souek, P.; Usová, S; Skálová, L. (2004) Res. Vet. Sci., 76, 43-51.
48. Van't Klooster, G.A.E.; Blaauboer, B.J.; Noordhoek, J.; Van Miert, A.S.J.P.A.M. (1993) Biochem. Pharmacol., 46, 1781-1790.
49. Danielson, T.J.; Golsteyn, L.R. (1996) Drug Met. Disp., 24, 1058-1061.
50. Butler, M.A.; Iwasaki, M.; Guengerich, F.P.; Kadlubar, F.F. (1989) Proc. Natl. Acad. Sci. USA, 86, 7696-7700.
51. Donato, M.T.; Castell, J.V.L.; Gómez-Lechón, J. (1999) J. Hepatol., 31, 542-549.
52. Myers, M.J.; Farrell, D.E.; Howard, K.D.; Kawalek, J.C. (2001) Drug Met. Dispos., 29, 908-915.
53. Baliharová, V.; Velík, J.; Avlik, M.; Szotáková, B.; Lamka, J.; Tahotná, L.; Skálová, L. (2004) J. vet. Pharmacol. Therap., 27, 85-90.
54. Jurima-Moret, M.; Casley, W.L.; Leblanc, C.A.; Nowakowska, M. (2000) Toxicol. In-Vitro, 14, 253-263.
55. Tjtta, K.; Aune, T. (1991) Mutat. Res., 251, 7-11.
56. Desille, M.; Corcos, L; L'Helgoual HA.; Frémond, B.; Campion, JP.; Guillouzo, A.; Bruno, C. (1999) Transplantation, 68, 1437-1443.
57. Monshouwer, M.; van't Klooster, G.A.E.; Nijmeijer, S.M.; Witkamp, R.F.; Van Miert, A.S.J.P.A.M. (1998) Toxicol. In-Vitro, 12, 715-723.
58. Van't Klooster, G.A.E.; Horbach, G.J.M.J.; Natsuhori, M.; Blaauboer, B.J.; Noordhoek, J.; Van Miert, A.S.J.P.A.M. (1993) Biochem. Pharmacol., 45, 113-122.
59. Zweers-Zeilmaker, W.M.; Maas, R.F.M.; Horbach, G.J.; Van Miert, A.S.J.P.A.M.; Witkamp, R.F. (1996) J. Vet. Pharmacol. Therap., 19, 245-250.
60. Machala, M.; Souek, P.; Nea, J.; Ulrich, R.; Lamka, J.; Szotáková, B.; Skálová, L. (2003) Arch. Toxicol., 77, 55-60.
61. Sivapathasundaram, S.; Magnisali, P.; Coldham, N.G.; Howells, L.C.; Sauer, M.J.; Ioannides, C. (2003) Toxicology, 187, 49-65.
62. Nebbia, C.; Dacasto, M.; Carletti, M. (2004) Life Sci., 74, 1605-1619.
63. Lakritz, J.; Winder, B.S.; Noorouz-Zadeh, J.; Huang, T.L.; Buckpitt, A.R.; Hammock, B.D.; Plopper, C.G. (2000) Am. J. Vet. Res., 61, 152-157.
64. Chauret, M.; Gauthier, A.; Martin, J.; Nicoll-Griffith, D. (1997) Drug Met. Dispos., 25, 1130-1136.
65. Kushida, H.; Fujita, K-I.; Suzuki, A.; Yamada, M.; Endo, T.; Nohmi, T.; Kamataki, T. (2000) Carcinogenesis, 21, 1277-1232.
66. Honkakoski, P.; Negishi, M. (1997) The structure, function, and regulation of cytochrome P450 2A enzymes. Drug Met. Rev., 29, 977-996.
67. Diaz, D.J.; Squires, E.J. (2000) Toxicol. Sci., 55, 284-292.
68. Skaanlid, M.T.; Friis, C. (2000) Pharmacol. Toxicol., 87, 174-178.
69. Lin, Z.; Squires, E.J. (2004) Animal Gen., 35, 314-316.
70. Lake, B.G.; Sauer, M.J.; Esclangon, F.; Beamand, J.A.; Price, R.J.; Walters, D.G. (1995) Xenobiotica, 25, 133-141.
71. Shu, L.; Hollenberg, P.F. (1997) Carcinogenesis, 18, 801-810.
72. Guengerich, F.P.; Butler, M.A.; McDonald, T.A.; Kadlubar, F.F. (1987) In Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes, (King, C.M.; Romano, L.J.; Schuetzle, D. Eds.), Elsevier Scientific Publishing, New York, pp. 89-95.
73. Code, E.L.; Crespi, C.L.; Penman, B.W.; Gonzalez, F.J.; Chang, T.K.H.; Waxman, D.J. (1997) Drug Met. Dispos., 25, 985-993.
74. Chang, T.L.K.H.; Weber, G.F.; Crespi, C.L.; Waxman, D.J. (1993) Cancer Res., 53, 5629-5637.
75. Roy, P.; Yu, L.J.; Crespi, C.L.; Waxman, D.J. (1999) Drug Met. Disp., 27, 655-666.
76. Mimura, M.; Baba, T.; Yamazaki, Y.; Ohmori, S.; Inui, Y.; Gonzalez, F.J.; Guengerich, F.P.; Shimada, T. (1993) Drug Met. Dispos., 21, 1048-1056.
77. Duringer, J.M.; Buhler, D.R. (2004) Am. J. Vet. Res., 65, 1563-1572.
78. Skálová, L.; Szotáková, B.; Machala, M.; Nea, J.; Souek, P.; Havlasová, J.; Wsól, V.; Kidová, L.; Kvasniková, E.; Lamka, J. (2001) Chem.-Biol. Interact., 137, 155-167.
79. Huan, J-Y.; Miranda, C.L.; Buhler, D.R.; Cheeke, P.R. (1998) Toxicol. Appl. Pharmacol., 151, 229-235.
80. Murray, M. (1991) J. Steroid Biochem. Mol. Biol., 38, 611-619.
81. Kaddouri, M.; Brasset, N.; Alvinerie, M.; Eeckhoutte, C.; Bonfils, C.; Derancourt, J.; Galtier, P. (1992) J. Steroid Biochem. Mol. Biol., 42, 499-508.
82. Van't Klooster, G.A.E.; Horbach, G.J.M.J.; Natsuhori, M.; Blaauboer, B.J.; Noordhoek, J.; Van Miert, A.S.J.P.A.M. (1993) Biochem. Pharmacol., 45, 113-122.
83. Nims, R.W.; Lubet, R.A. (1996) In Cytochromes P450: Metabolic and Toxicological Aspects, (Ioannides, C. Ed.), CRC Press Inc, Boca Raton, pp. 135-160.
84. Shimada, T.; Iwasaki, M.; Martin, M.V.; Guengerich, F.P. (1989) Cancer Res., 49, 3218-3228.
85. Zhou, H.L.; Anthony, L.B.; Wood, A.J.; Wilkinson, G.R. (1990) Br. J. Clin. Pharmacol., 30, 471-475.
86. Zweers-Zeilmaker, W.M.; Horbach, G.J.; Witkamp, R.F. (1998) J. vet. Pharmacol. Therap., 21, 154-157.
87. Zeilmaker, W.M.; van't Klooster, G.A.E.; Fink Gremmels-Gehrmann, J.; van Miert, A.S.J.P.A.M.; Horbach, G.J.M.J. (1994) Biochem. Biophys. Res. Commun., 200, 120-125.
88. Zweers-Zeilmaker, W.M.; Batzias, J.; Maas, R.F.M., Horbach, G.J.; Van Miert, A.S.J.P.A.M.; Witkamp, R.F. (1996) Xenobiotica, 26, 1131-1141.
89. Zweers-Zeilmaker, W.M.; Horbach, G.J.; Witkamp, R.F. (1997) Xenobiotica, 27, 769-780.
90. Komori, M.; Higami, A.; Imai, Y.; Imaoka, S.; Funae, Y. (1993) J. Biochem., 114, 445-448.
91. Gonzalez, F.J. (1996) In Cytochromes P450: Metabolic and Toxicological Aspects, (Ioannides, C. Ed.), CRC Press Inc, Boca Raton, pp. 183-210.
92. Hiroi, T.; Chow, T.; Imaoka, S.; Funae, Y. (2002) Drug Met. Disp., 30, 970-976.
93. Tsuneoka, Y; Matsuo, Y; Higuchi, R; Ichikawa, Y (1992) Eur. J. Biochem., 208, 739-746.
94. Matsuo, Y; Iwahashi, K; Ichikawa, Y. (1992) Biochem. Pharmacol., 43, 1911-1919.
95. Jurima-Romet, M; Casley, W.L.; Leblanc, C.A.; Nowakowska, M. (2000) Toxicol. In vitro, 14, 253-263.
96. Skaanlid, M.T.; Friis, C. (2002) Pharmacol. Toxicol., 91, 198-203.
97. Hosseinpour, F.; Wikvall, K. (2000) J. Biol. Chem., 275, 34650-34655.
98. Lewis, D.F.V.; Ioannides, C.; Parke, D.V. (1993) Mutat. Res., 291, 61-77.
99. Kamataki, T.; Fujita, K-i.; Nakayama, K.; Yamazaki, Y.; Miyamoto, M.; Ariyoshi, N. (2002) Drug Met. Rev., 34, 667-676.
100. Sohn, O.S.; Fiala, E.S.; Requeijo, S.P.; Weisburger, J.H.; Gonzalez, F.J. (2001) Cancer Res., 61, 8435-8440
101. Pirmohamed, M.; Park, B.K. In Cytochromes P450: Metabolic and Toxicological Aspects, (Ioannides, C. Ed.), CRC Press Inc, Boca Raton, pp. 329-354.
102. Ronis, M.J.J.; Lindros, K.O.; Ingelman-Sundberg, M. In Cytochromes P450: Metabolic and Toxicological Aspects, (Ioannides, C. Ed.) CRC Press Inc, Boca Raton, 1996, pp. 211-239.
103. Kessova, I.; Cederbaum, A.I. (2003) Current Mol. Med., 3, 509-518.
104. Raucy, J.L. (1995) Toxicology, 105, 217-224.
105. Court, M.H.; von Moltke, L.L.; Shader, R.I.; Greenblatt, D.J. (1997) Biopharm. Drug Dispos., 18, 213-226.
106. Lejus, C.; Fautrel, A.; Mallédant, Y.; Guillouzo, A. (2002) Biochem. Pharmacol., 64, 1151-1156.
107. Squires, E.J.; Lundström, K. (1997) J. Anim. Sci., 75, 2506-2511.
108. Cox, S.K.; Hamner, T.; Bartges, J. (2003) J. Chromatogr. B, 784, 111-116.
109. Doran, E.; Whittington, F.W.; Wood, J.D.; McGivan, J.D. (2002) Chem.-Biol. Interact., 140, 81-92.
110. Babol, J.; Squires, J.; Lundström, K. (1998) J. Anim. Sci., 76, 822-828.
111. Thummel, K.E.; Wilkinson, G.R. (1998) Ann. Rev. Pharmacol. Toxicol., 38, 389-430.
112. Kolars, J.C.; Schmiedlin-Ren, P.; Schuetz, J.D.; Fang, C.; Watkins, P.B. (1992) J. Clin. Invest., 90, 1871-1878.
113. McKinnon, R.A.; Burgess, W.M.; Hall, M.P.; Roberts-Thomson, S.J.; Gonzalez, F.J.; McManus, M.E. (1995) Gut, 36, 259-267.
114. Maurel, P. (1996) In Cytochromes P450: Metabolic and Toxicological Aspects, (Ioannides, C. Ed.), CRC Press Inc, Boca Raton, 1996, pp. 241-270.
115. McCune, J.S.; Hawke, R.L.; LeCluyse, E.L.; Gillenwater, H.H.; Hamilton, G.; Ritchie, J.; Lindley, C. (2000) Clin. Pharmacol. Ther., 68, 356-366.
116. Lewis, D.F.V.; Eddershaw, P.J.; Goldfarb, P.J.; Tarbit, M.H. (1996) Xenobiotica, 26, 1067-1086.
117. Aoyama, T.; Yamano, S.; Guzelian, P.S.; Gelboin, H.V.; Gonzalez, H.V. (1990) Proc. Natl. Acad. Sci. USA, 87, 4790-4793.
118. Kitada, M.; Taneda, M.; Ohta, K.; Nagashima, K.; Itahashi, K.; Kamataki, T. (1990) Cancer Res., 50, 2641-2645.
119. Roberts-Thompson, S.J.; McManus, M.E.; Tukey, R.H.; Gonzalez, F.J.; Holder, G.M. (1995) Cancer Res., 55, 1052-1059.
120. Miranda, C.L.; Reed, R.L.; Guengerich, F.P.; Buhler, D.R. (1992) Carcinogenesis, 12, 515-519.
121. LeDuc, B.; Sinclair, P.; Shuster, L.; Sinclair, J.F.; Evans, J.E.; Greenblatt, D.J. (1992) Pharmacology, 46, 294-300.
122. Pasanen, M.; Pellinen, P.; Stenback, F.; Juvonen, R.A.; Raunio, H.; Pelkonen, O. (1995) Arch. Toxicol., 69, 287-290.
123. Natsuhori, M.; van Raak, M.; Lightenberg, M.; Klej, V.; ten Berge, D.; Zweers-Zeilmaker, W.M.; de Groene, E.M.; van Miert, A.S.J.P.A.M.; Witkamp, R.F.; Horbach, G.J. (1997) Environm. Toxicol. Pharmacol., 3, 17-24.
124. Dacasto, M.; Eeckhoutte, C.; Capolongo, F.; Dupuy, J.; Carletti, M.; Calléja, C.; Alvinerie, M.; Galtier, P. (2005) Vet. Res., 36, 179-190.
125. Kuilman, M.E.M.; Maas, R.F.M.; Judah, D.J.; Fing-Gremmels, J. (1998) J. Agric. Food Chem., 46, 2707-2713.
126. Hosagrahara, V.P.; Hansen, L.K.; Remmel, R.P. (1999) Drug Metab. Dispos., 27, 1512-1518.
127. Olsen, A.K.; Hansen, K.T.; Friis, C. (1997) Chem.-Biol. Interact., 107, 93-108.
128. Guengerich, F.P. (1990) Chem. Res. Toxicol., 3, 363-371.
129. Chang, T.K.; Gonzalez, F.J.; Waxman, D.J. (1994) Arch. Biochem. Biophys., 311, 437-442.
130. Pineau, T.; Galtier, P.; Bonfils, C.; Derancourt, J.; Maurel, P. (1990) Biochem. Pharmacol., 12, 515-519.
131. Calléja, C.; Bigot, K.; Eeckhoutte, C.; Sibille, P.; Boulard, C.; Galtier, P. (2000) Intern. J. Parasitol., 30, 953-958.
132. Tydén, E.; Olsén, L.; Tallkvist, J.; Larsson, P.; Tjälve, H. (2004) Toxicol. Appl. Pharmacol., 201, 112-119.
133. Sivapathasundaram, S.; Howells, L.C.; Sauer, M.J.; Ioannides, C. (2004) J. Vet. Pharmacol. Ther., 27, 79-84.
134. Eltom, S.E.; Park, S.-S.; Schwark, W.S. (1993) Dev. Pharmacol. Ther., 20, 93-99.